title: Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesis.
abstract: High-risk human papillomaviruses (HPV) encode two oncogenes, E6 and E7, expressed in nearly all cervical cancers. In vivo, HPV-16 E7 has been shown to induce multiple phenotypes in the context of transgenic mice, including cervical cancer. E7 is a multifunctional protein known best for its ability to inactivate the tumor suppressor pRb. To determine the importance of pRb inactivation by E7 in cervical cancer, we pursued studies with genetically engineered mice. E7 expression in estrogen-treated murine cervix induced dysplasia and invasive cancers as reported previously, but targeted Rb inactivation in cervical epithelium was not sufficient to induce any cervical dysplasia or neoplasia. Furthermore, E7 induced cervical cancer formation even when the E7-pRb interaction was disrupted by the use of a knock-in mouse carrying an E7-resistant mutant Rb allele. pRb inactivation was necessary but not sufficient for E7 to overcome differentiation-induced or DNA damage-induced cell cycle arrest, and expression patterns of the E2F-responsive genes Mcm7 and cyclin E indicate that other E2F regulators besides pRb are important targets of E7. Together, these data indicate that non-pRb targets of E7 play critical roles in cervical carcinogenesis.
authors.affiliation: McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison, WI 53706, USA.
authors.forename: Scott
authors.initials: S
authors.lastname: Balsitis
authors.forename: Fred
authors.initials: F
authors.lastname: Dick
authors.forename: Nicholas
authors.initials: N
authors.lastname: Dyson
authors.forename: Paul F
authors.initials: PF
authors.lastname: Lambert
mesh_terms: D000483:Alleles; D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000235:genetics* / Q000821:virology; D002453:Cell Cycle; D018797:Cell Cycle Proteins / Q000502:physiology; D002454:Cell Differentiation; D002472:Cell Transformation, Viral / Q000235:genetics*; D019927:Cyclin E / Q000502:physiology; D004249:DNA Damage; D004268:DNA-Binding Proteins / Q000502:physiology; D004967:Estrogens / Q000633:toxicity; D005260:Female; D018390:Gene Targeting; D016161:Genes, Retinoblastoma; D052162:Human papillomavirus 16 / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D008822:Mice, Transgenic; D064168:Minichromosome Maintenance Complex Component 7; D009687:Nuclear Proteins / Q000502:physiology; D009856:Oncogene Proteins, Viral / Q000235:genetics / Q000502:physiology*; D050725:Papillomavirus E7 Proteins; D030361:Papillomavirus Infections / Q000235:genetics*; D002583:Uterine Cervical Neoplasms / Q000235:genetics* / Q000821:virology; D002578:Uterine Cervical Dysplasia / Q000235:genetics
chemical_list: D018797:Cell Cycle Proteins; D019927:Cyclin E; D004268:DNA-Binding Proteins; D004967:Estrogens; D009687:Nuclear Proteins; D009856:Oncogene Proteins, Viral; D050725:Papillomavirus E7 Proteins; C059731:oncogene protein E7, Human papillomavirus type 16; C491086:Mcm7 protein, mouse; D064168:Minichromosome Maintenance Complex Component 7